ArticleBioresources and bioprocessing2025
Sustainable β-carotene production by engineered S. cerevisiae using sucrose and agricultural by-products.
Article in Bioresources and bioprocessing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Yeasts associated with microalgal cultures in marine environments: ecological roles and biotechnological potential.FEMS yeast research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
β-carotene, a carotenoid precursor to vitamin A, is widely employed in the food, pharmaceutical, and nutraceutical sectors. In this study, we present an economically sustainable strategy for β-carotene biosynthesis in Saccharomyces cerevisiae by engineering the yeast to utilize sucrose and agricultural by-products as alternative carbon and nitrogen sources. Specifically, the deletion of the GAL80 gene facilitated effective β-carotene synthesis directly from sucrose, circumventing the costly requirement for galactose induction. Using this engineered yeast strain, we achieved β-carotene titers of up to 23.30 ± 4.22 mg/L and content levels of 2.29 ± 0.16 mg/g dry cell weight (DCW). To further improve the economic viability and environmental sustainability, we evaluated the use of agricultural by-products-molasses as a carbon source and fish meal as a nitrogen source-in a fed-batch fermentation process, highlighting the potential of these substrates to replace refined feedstocks while achieving competitive β-carotene production levels. This approach yielded substantial β-carotene titers of 17.02 ± 0.40 mg/L and content levels of 2.90 ± 0.21 mg/g DCW. It also significantly reduced medium costs by up to 73% compared to conventional yeast extract and peptone-based media, demonstrating the practical potential of these low-cost, sustainable substrates for industrial applications. This study uniquely highlights the successful application of unrefined agricultural by-products, addressing key challenges in cost and sustainability. These findings represent an important advancement toward developing economically competitive and environmentally responsible microbial platforms for the production of β-carotene and other high-value biochemicals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.